Cargando…

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors

PURPOSE: There are few effective biomarkers for neuroendocrine tumors. Precision oncology strategies have provided liquid biopsies for real-time and tailored decision-making. This has led to the development of the first neuroendocrine tumor liquid biopsy (the NETest). The NETest represents a transcr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malczewska, Anna, Kos-Kudła, Beata, Kidd, Mark, Drozdov, Ignat, Bodei, Lisa, Matar, Somer, Oberg, Kjell, Modlin, Irvin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453408/ https://www.ncbi.nlm.nih.gov/pubmed/31841822 http://dx.doi.org/10.1016/j.advms.2019.10.002

Ejemplares similares

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
por: Malczewska, Anna, et al.
Publicado: (2019)

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis
por: Malczewska, Anna, et al.
Publicado: (2020)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017)

Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosis
por: Kidd, Mark, et al.
Publicado: (2019)

Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015)

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
por: Malczewska, A., et al.
Publicado: (2020)

Blood transcript analysis and metastatic recurrent small bowel carcinoid management
por: Modlin, Irvin M, et al.
Publicado: (2014)

The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
por: Modlin, Irvin M., et al.
Publicado: (2013)

A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
por: Modlin, Irvin M, et al.
Publicado: (2014)

Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors
por: Kidd, Mark, et al.
Publicado: (2014)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020)

Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine Neoplasia
por: Drozdov, Ignat, et al.
Publicado: (2011)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
por: Oberg, Kjell, et al.
Publicado: (2016)

Imaging and liquid biopsy in the prediction and evaluation of response to PRRT in neuroendocrine tumors: implications for patient management
por: Roll, Wolfgang, et al.
Publicado: (2021)

A metastatic tumor is no different to a viral pandemic: lessons learnt from COVID-19 may teach us to change the PRRT paradigm
por: Paganelli, Giovanni, et al.
Publicado: (2020)

Treatment of neuroendocrine tumors: new recommendations based on the CLARINET study
por: Kos-Kudła, Beata
Publicado: (2015)

A combination of surgery, theranostics, and liquid biopsy - a personalised oncologic approach to treatment of patients with advanced metastatic neuroendocrine neoplasms
por: Frilling, Andrea, et al.
Publicado: (2021)

Role of Leptin and Adiponectin in Carcinogenesis
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems
por: Clift, Ashley K, et al.
Publicado: (2017)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

Minichromosome Maintenance Expression Defines Slow-Growing Gastroenteropancreatic Neuroendocrine Neoplasms()
por: Schimmack, Simon, et al.
Publicado: (2016)

Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
por: Giovinazzo, Francesco, et al.
Publicado: (2013)

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
por: Dromain, Clarisse, et al.
Publicado: (2021)

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
por: Rosiek, Violetta, et al.
Publicado: (2023)

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
por: Rosiek, Violetta, et al.
Publicado: (2023)

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
por: Rosiek, Violetta, et al.
Publicado: (2023)

Diagnostic work-up of gastroenteropancreatic neuroendocrine tumors
por: Öberg, Kjell
Publicado: (2012)

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors – results of interim analysis
por: Orlewska, Ewa, et al.
Publicado: (2014)

Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
por: Gossing, Wilhelm, et al.
Publicado: (2020)

Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
por: Öberg, Kjell
Publicado: (2012)

A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases
por: Schimmack, Simon, et al.
Publicado: (2014)

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
por: Kos-Kudła, Beata, et al.
Publicado: (2017)

Selected Parameters of Bone Turnover in Neuroendocrine Tumors—A Potential Clinical Use?
por: Strzelczyk, Janusz, et al.
Publicado: (2023)

Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia
por: Lawrence, Ben, et al.
Publicado: (2012)

Assessment of the Concentration of Endogenous Factors Regulating Angiogenesis, VASH-1 and VEGF-A, in the Blood Serum of Patients with Neuroendocrine Neoplasms
por: Strzelczyk, Janusz, et al.
Publicado: (2022)

The Potential Role of Liquid Biopsies in Advancing the Understanding of Neuroendocrine Neoplasms
por: Shah, Dinakshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_42bruacqfsmq87ntoo47qdajnr